TBC1D4 inhibitors belong to a specific chemical class that interacts with and modulates the activity of TBC1D4, a crucial protein involved in cellular signaling and regulation. TBC1D4, also known as AS160, plays a pivotal role in the intricate process of glucose metabolism and cellular transportation. The inhibitors that target TBC1D4 are designed to interact with specific binding sites on the protein's structure, consequently altering its functional behavior. By doing so, these inhibitors may potentially influence various cellular processes that are under the regulation of TBC1D4. TBC1D4 is recognized for its participation in insulin-regulated glucose uptake, which is a fundamental process for maintaining blood glucose levels within a healthy range. It is primarily found in insulin-sensitive tissues such as skeletal muscle and adipose tissue, where it contributes to the translocation of glucose transporter proteins to the cell surface. This translocation allows the efficient uptake of glucose from the bloodstream into the cells, supporting energy production and storage.
TBC1D4 inhibitors, by virtue of their interaction with the TBC1D4 protein, may impact the intricate balance of cellular processes involved in glucose homeostasis. These inhibitors are thought to modulate the intracellular trafficking of glucose transporter proteins, influencing their translocation and subsequent glucose uptake. Furthermore, TBC1D4 inhibitors might also affect other downstream signaling pathways connected to TBC1D4, potentially leading to broader cellular responses beyond glucose metabolism. In conclusion, TBC1D4 inhibitors constitute a distinctive class of chemicals recognized for their ability to interact with the TBC1D4 protein. By targeting specific binding sites, these inhibitors hold the potential to modify the protein's function and influence various cellular processes related to glucose metabolism and cellular transportation. Their impact on intracellular trafficking and downstream signaling pathways underscores their significance in cellular physiology and highlights their potential for further exploration in the field of molecular research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
An AMP-activated protein kinase (AMPK) activator that indirectly affects TBC1D4 through AMPK-mediated signaling. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
A natural compound that has been shown to improve glucose metabolism and insulin sensitivity by affecting TBC1D4 and other pathways. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
A commonly used agent in research for type 2 diabetes that can impact glucose uptake and TBC1D4 function indirectly through its effects on AMPK. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Another natural compound that may impact TBC1D4-mediated glucose uptake through various mechanisms. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid with potential antidiabetic effects, which may involve TBC1D4-related pathways. | ||||||